{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T11:55:16Z","timestamp":1778586916988,"version":"3.51.4"},"reference-count":15,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82274491"],"award-info":[{"award-number":["82274491"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82074348"],"award-info":[{"award-number":["82074348"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["202225014"],"award-info":[{"award-number":["202225014"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA151354"],"award-info":[{"award-number":["R01CA151354"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Cell Research"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.yexcr.2024.114273","type":"journal-article","created":{"date-parts":[[2024,10,5]],"date-time":"2024-10-05T02:14:37Z","timestamp":1728094477000},"page":"114273","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Changes in the immune microenvironment during plasma cell tumor development in the IL6Myc mouse model of human multiple myeloma"],"prefix":"10.1016","volume":"442","author":[{"given":"Manya","family":"Yu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vivian","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael D.","family":"Pisano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2229-5511","authenticated-orcid":false,"given":"Siegfried","family":"Janz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xing","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.yexcr.2024.114273_bib1","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1038\/s41591-022-02178-3","article-title":"Preclinical models for prediction of immunotherapy outcomes and immune evasion mechanisms in genetically heterogeneous multiple myeloma","volume":"29","author":"Larrayoz","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.yexcr.2024.114273_bib2","article-title":"Different evasion strategies in multiple myeloma","volume":"15","author":"Wang","year":"2024","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.yexcr.2024.114273_bib3","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1007\/s12185-023-03579-x","article-title":"Immune dysregulation in multiple myeloma: the current and future role of cell-based immunotherapy","volume":"117","author":"Russell","year":"2023","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.yexcr.2024.114273_bib4","doi-asserted-by":"crossref","DOI":"10.1038\/bcj.2013.61","article-title":"(18)F-FDG-PET\/CT imaging in an IL-6- and MYC-driven mouse model of human multiple myeloma affords objective evaluation of plasma cell tumor progression and therapeutic response to the proteasome inhibitor ixazomib","volume":"3","author":"Duncan","year":"2013","journal-title":"Blood Cancer J."},{"issue":"9","key":"10.1016\/j.yexcr.2024.114273_bib5","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1182\/blood-2009-08-237941","article-title":"IL-6 and MYC collaborate in plasma cell tumor formation in mice","volume":"115","author":"Rutsch","year":"2010","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.yexcr.2024.114273_bib6","doi-asserted-by":"crossref","first-page":"e111","DOI":"10.3324\/haematol.2019.221127","article-title":"Osteolytic disease in IL-6 and Myc dependent mouse model of human myeloma","volume":"105","author":"Sun","year":"2020","journal-title":"Haematologica"},{"issue":"12","key":"10.1016\/j.yexcr.2024.114273_bib7","doi-asserted-by":"crossref","first-page":"3372","DOI":"10.3324\/haematol.2022.282538","article-title":"IL6Myc mouse is an immunocompetent model for the development of aggressive multiple myeloma","volume":"108","author":"Pisano","year":"2023","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.yexcr.2024.114273_bib8","doi-asserted-by":"crossref","first-page":"7509","DOI":"10.1038\/s41467-023-43416-7","article-title":"Anti-TACI single and dual-targeting CAR T cells overcome BCMA antigen loss in multiple myeloma","volume":"14","author":"Larson","year":"2023","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.yexcr.2024.114273_bib9","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41467-021-27853-w","article-title":"A BAFF ligand-based CAR-T cell targeting three receptors and multiple B cell cancers","volume":"13","author":"Wong","year":"2022","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.yexcr.2024.114273_bib10","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.blre.2016.04.002","article-title":"Myeloid-derived suppressor cells: the green light for myeloma immune escape","volume":"30","author":"Malek","year":"2016","journal-title":"Blood Rev."},{"issue":"2","key":"10.1016\/j.yexcr.2024.114273_bib11","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13020217","article-title":"The role of tumor microenvironment in multiple myeloma development and progression","volume":"13","author":"Garcia-Ortiz","year":"2021","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.yexcr.2024.114273_bib12","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1046\/j.1365-2141.2003.04260.x","article-title":"CD27 is heterogeneously expressed in multiple myeloma: low CD27 expression in patients with high-risk disease","volume":"121","author":"Guikema","year":"2003","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.yexcr.2024.114273_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.663748","article-title":"Predictive role of immune profiling for survival of multiple myeloma patients","volume":"12","author":"Zhaoyun","year":"2021","journal-title":"Front. Immunol."},{"issue":"670","key":"10.1016\/j.yexcr.2024.114273_bib14","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abm1463","article-title":"Pooled screening of CAR T cells identifies diverse immune signaling domains for next-generation immunotherapies","volume":"14","author":"Goodman","year":"2022","journal-title":"Sci. Transl. Med."},{"issue":"6","key":"10.1016\/j.yexcr.2024.114273_bib15","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-006699","article-title":"Limited efficacy of APRIL CAR in patients with multiple myeloma indicate challenges in the use of natural ligands for CAR T-cell therapy","volume":"11","author":"Lee","year":"2023","journal-title":"J Immunother Cancer"}],"container-title":["Experimental Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482724003641?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482724003641?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T19:23:38Z","timestamp":1777404218000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014482724003641"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S0014482724003641"],"URL":"https:\/\/doi.org\/10.1016\/j.yexcr.2024.114273","relation":{},"ISSN":["0014-4827"],"issn-type":[{"value":"0014-4827","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Changes in the immune microenvironment during plasma cell tumor development in the IL6Myc mouse model of human multiple myeloma","name":"articletitle","label":"Article Title"},{"value":"Experimental Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexcr.2024.114273","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114273"}}